Skip to main content

Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.

Publication ,  Journal Article
Frothingham, R
Published in: Arch Intern Med
July 13, 1998

Duke Scholars

Published In

Arch Intern Med

DOI

ISSN

0003-9926

Publication Date

July 13, 1998

Volume

158

Issue

13

Start / End Page

1470 / 1472

Location

United States

Related Subject Headings

  • Zidovudine
  • United States
  • Occupational Exposure
  • Lamivudine
  • Indinavir
  • Humans
  • HIV Infections
  • General & Internal Medicine
  • Cost-Benefit Analysis
  • Anti-HIV Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Frothingham, R. (1998). Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med, 158(13), 1470–1472. https://doi.org/10.1001/archinte.158.13.1470-a
Frothingham, R. “Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.Arch Intern Med 158, no. 13 (July 13, 1998): 1470–72. https://doi.org/10.1001/archinte.158.13.1470-a.
Frothingham R. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med. 1998 Jul 13;158(13):1470–2.
Frothingham, R. “Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.Arch Intern Med, vol. 158, no. 13, July 1998, pp. 1470–72. Pubmed, doi:10.1001/archinte.158.13.1470-a.
Frothingham R. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Arch Intern Med. 1998 Jul 13;158(13):1470–1472.

Published In

Arch Intern Med

DOI

ISSN

0003-9926

Publication Date

July 13, 1998

Volume

158

Issue

13

Start / End Page

1470 / 1472

Location

United States

Related Subject Headings

  • Zidovudine
  • United States
  • Occupational Exposure
  • Lamivudine
  • Indinavir
  • Humans
  • HIV Infections
  • General & Internal Medicine
  • Cost-Benefit Analysis
  • Anti-HIV Agents